A current article posted on the NCI Cancer suggest that cancer researchers recognize the potential that synthetic biologist. Especially the efforts to engineer bacterial cells that selectively target cancer cells by Dr. Chris Anderson (who is also the supervisor for UC Berkley's team). The interest that the Division of Cancer Biology has with Synthetic Biology is its application through the combination of various fields including biology, engineering, chemistry and physics which they hope will offer new insights into ongoing cancer research.
Heres the video of Dr. Jerry Li the program director in NCI’s Division of Cancer Biology (DCB) and his colleague Dr. Daniel Gallahan discuss the potentials of synthetic biology.
Original article can be found on:
http://www.cancer.gov/ncicancerbulletin/071310/page4
Jeremy
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment